AI-Enabled X-Ray Imaging Solutions Market Overview, Analysis And Demand By 2034


Use Code ONLINE20 to Save 20% On Global Market Reports – Gain Access to Trusted Market Data, Growth Indicators, and Industry Analytics

What Is the Current Size and Annual Growth Rate of the AI-Enabled X-Ray Imaging Solutions Market?
The ai-enabled x-ray imaging solutions market size has grown rapidly in recent years. It will grow from $2.17 billion in 2024 to $2.44 billion in 2025 at a compound annual growth rate (CAGR) of 12.4%. The growth in the historic period can be attributed to regulatory approvals, a rise in healthcare costs, increased demand for diagnostic accuracy, an increased shortage of radiologists, and an aging population.

The ai-enabled x-ray imaging solutions market size is expected to see rapid growth in the next few years. It will grow to " $3.8 billion in 2029 at a compound annual growth rate (CAGR) of 11.8%. The growth in the forecast period can be attributed to integration with electronic health records, adoption of value-based care models, expanding applications in telemedicine, the emergence of AI-enabled triage systems, and demand for personalized medicine. Major trends in the forecast period include continued growth in AI-enabled diagnostic accuracy and efficiency, integration of AI with other imaging modalities beyond X-ray, development of AI-driven predictive analytics, and focus on regulatory standards and ethical considerations in AI implementation.

Get your free report sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15303&type=smp

What Are the Primary Factors Driving the AI-Enabled X-Ray Imaging Solutions Market?
The growing demand for personalized medicine is expected to propel the growth of the AI-enabled X-ray imaging solutions market. Personalized medicines, also known as precision medicine, are a category of medical treatments and therapies that are tailored to the specific characteristics of individual patients. The demand for personalized medicine increases because of advancements in genomic research, increased understanding of disease heterogeneity, and technological innovations. Personalized medicine enhances the role of AI-enabled X-ray imaging solutions by customizing healthcare interventions, treatment strategies, and imaging protocols to the individual characteristics and needs of each patient. For instance, in October 2022, according to the Personalized Medicine Coalition (PMC), a US-based organization that promotes the understanding and adoption of personalized medicine, there were more than 75,000 genetic testing products and 300 personalized medicines. Further, in 2023, the FDA (the United States Food and Drug Administration), a US-based federal agency, approved new drugs, of which 38% were personalized medicines. Therefore, the growing demand for personalized medicine is driving the growth of the AI-enabled X-ray imaging solutions market.

How Is the AI-Enabled X-Ray Imaging Solutions Market Categorized Based on Key Segments?
The ai-enabled x-ray imaging solutionsmarket covered in this report is segmented –

1) By Product: Software; Hardware
2) By Mode Of Deployment: Cloud-Based And Web-Based; On-Premises
3) By Workflow: Detection; Image Acquisition; Image Analysis; Diagnosis And Treatment Decision Support; Triage; Predictive Analysis and Risk Assessment; Reporting And Communication
4) By Application: General Radiology; Specialty Radiology

Which Major Trends Are Expected to Define the AI-Enabled X-Ray Imaging Solutions Market Through 2029?
Major companies operating in the AI-enabled X-ray imaging solutions market are developing advanced solutions, such as fixed AI-enabled X-ray systems, to improve efficiency with in-room workflows, reduce strain with patient positioning, and ensure robust image quality. This X-ray imaging solution refers to the integration of artificial intelligence (AI) technology into X-ray imaging systems to enhance the analysis, interpretation, and utilization of X-ray images for medical diagnosis and treatment planning. For instance, in August 2022, GE HealthCare Technologies Inc., a US-based medical technology company, launched the Definium 656 HD, a new fixed AI-enabled X-ray system featuring enhanced, artificial intelligence (AI)-driven image processing to facilitate radiology workflows and reduce patient positioning time. The Definium 656 HD system has several features that help to ensure effective image acquisition and lessen the physical difficulties associated with patient posture. The following features, according to GE Healthcare, are included in this list: 3-dimensional camera technology via the Intelligent Workflow Suite of the system, which allows for more consistent image quality and reduces the need for needless repeat X-rays, and a 12-inch touchscreen on the tube head console that makes automated adjustments to in-room workflows.

Who Are the Major Companies Operating in the AI-Enabled X-Ray Imaging Solutions Market?
Major companies operating in the AI-enabled X-ray imaging solutions market are Samsung Electronics Co. Ltd., General Electric Company, International Business Machines Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., Agfa-Gevaert NV, Carestream Health Inc., Fujifilm Healthcare Americas Corporation, Canon Medical Systems Corporation, Lunit Inc., Infervision Medical Technology Co. Ltd., Behold AI Technologies Limited, DeepTek.ai Inc., Quibim S.L., Enlitic Inc., Thirona BV, Arterys Inc., AI Technologies Limited, Konica Minolta Inc., Vuno Co. Ltd., Zebra Medical Vision Inc., Radiobotics APS, Digitec Innovation Srl, Imagen Technologies Inc.

Get the detailed ai-enabled x-ray imaging solutions market report today
https://www.thebusinessresearchcompany.com/report/ai-enabled-x-ray-imaging-solutions-global-market-report

Which Region Holds the Largest Share of the AI-Enabled X-Ray Imaging Solutions Market?
North America was the largest region in the AI-enabled X-ray imaging solutions market in 2024. It is expected to be the fastest-growing region in the forecast period. The regions covered in the AI-enabled X-ray imaging solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:
The Business Research Company: https://thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more